{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T20:48:55Z","timestamp":1794948535756,"version":"4.9.1"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:00:00Z","timestamp":1572998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:p>Commenting on a recently published article on sicca syndrome linked to immune checkpoint inhibitor therapy, this letter to the editor shares another viewpoint on the management of this immune-related adverse event.<\/jats:p>","DOI":"10.1634\/theoncologist.2019-0467","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T19:35:11Z","timestamp":1573068911000},"page":"e391-e395","source":"Crossref","is-referenced-by-count":36,"title":["Sicca Syndrome Induced by Immune Checkpoint Inhibitor Therapy: Optimal Management Still Pending"],"prefix":"10.1093","volume":"25","author":[{"given":"Ariadna","family":"Ortiz Brugu\u00e9s","sequence":"first","affiliation":[{"name":"Hospital Santa Caterina, Girona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Sibaud","sequence":"additional","affiliation":[{"name":"Department of Oncodermatology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Herbault-Barr\u00e9s","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Betrian","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iphigenie","family":"Korakis","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"De Bataille","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Gomez-Roca","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Epstein","sequence":"additional","affiliation":[{"name":"Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Vigarios","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,11,6]]},"reference":[{"key":"2021122510121746600_R1","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1634\/theoncologist.2018-0823","article-title":"Sicca syndrome associated with immune checkpoint inhibitor therapy","volume":"24","author":"Warner","year":"2019","journal-title":"The Oncologist"},{"key":"2021122510121746600_R2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sj\u00f6gren's syndrome: A consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021122510121746600_R3","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/annrheumdis-2016-210820","article-title":"Onset of connective tissue disease following anti-PD1\/PD-L1 cancer immunotherapy","volume":"77","author":"Le Burel","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2021122510121746600_R4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s40425-018-0429-4","article-title":"A severe case of neuro-Sj\u00f6gren's syndrome induced by pembrolizumab","volume":"6","author":"Ghosn","year":"2018","journal-title":"J Immunother Cancer"},{"key":"2021122510121746600_R5","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00520-017-3629-4","article-title":"Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors","volume":"25","author":"Vigarios","year":"2017","journal-title":"Support Care Cancer"},{"key":"2021122510121746600_R6","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000412","article-title":"Rheumatic immune-related adverse events of checkpoint therapy for cancer: Case series of a new nosological entity","volume":"3","author":"Calabrese","year":"2017","journal-title":"RMD Open"},{"key":"2021122510121746600_R7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/annrheumdis-2016-209595","article-title":"Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab","volume":"76","author":"Cappelli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2021122510121746600_R8","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1093\/annonc\/mdx531","article-title":"Gougerot-Sjogren-like syndrome under PD-1 inhibitor treatment","volume":"28","author":"Teyssonneau","year":"2017","journal-title":"Ann Oncol"},{"key":"2021122510121746600_R9","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.322","article-title":"Nivolumab-induced sialadenitis","volume":"6","author":"Takahashi","year":"2018","journal-title":"Respirol Case Rep"},{"key":"2021122510121746600_R10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.autrev.2018.05.002","article-title":"Rheumatic immune-related adverse events in patients on anti-PD-1 inhibitors: Fasciitis with myositis syndrome as a new complication of immunotherapy","volume":"17","author":"Narv\u00e1ez","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2019-0467","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2019-0467","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/25\/2\/e391\/41919572\/oncolo_25_2_e391.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/25\/2\/e391\/41919572\/oncolo_25_2_e391.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T10:12:55Z","timestamp":1640427175000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/25\/2\/e391\/6443298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":10,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,11,6]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2019-0467","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,2,1]]},"published":{"date-parts":[[2019,11,6]]}}}